XDEV:XETRA:XETRA-Xtrackers MSCI World Value UCITS ETF 1C EUR (EUR)

ETF | Others |

Last Closing

USD 43.565

Change

-0.25 (-0.56)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.87 (-4.25%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.83 (-4.92%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-1.19 (-5.21%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.49 (-3.83%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.28 (-5.29%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.93 (-4.19%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.70 (-5.54%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.37 (-2.45%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.34 (-3.39%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.03 (-0.02%)

USD 12.26B

ETFs Containing XDEV:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.76% 75% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.76% 77% C+ 70% C-
Trailing 12 Months  
Capital Gain 6.17% 62% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.17% 63% D 62% D
Trailing 5 Years  
Capital Gain 100.48% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.48% 73% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 13.76% 78% C+ 77% C+
Dividend Return 13.76% 77% C+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.95% 52% F 62% D
Risk Adjusted Return 115.21% 95% A 95% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike